Zobrazeno 1 - 5
of 5
pro vyhledávání: '"D. А. Kudlay"'
Publikováno v:
Туберкулез и болезни лёгких, Vol 100, Iss 4, Pp 6-13 (2022)
In some infectious diseases, the number of T- and B-lymphocytes is significantly reduced which is associated with a high risk of the disease progression. The article reviews the effect of two RNA-containing viruses on the specific immune system: SARS
Externí odkaz:
https://doaj.org/article/f7e68c0ea2a8480b8b82bc21a5839642
Autor:
V. А. Аksenova, А. V. Gordina, S. А. Sterlikov, D. А. Kudlay, D. А. Kucheryavaya, N. P. Doktorova
Publikováno v:
Туберкулез и болезни лёгких, Vol 100, Iss 1, Pp 26-32 (2022)
The objective: to evaluate the impact of active case finding in children 7-15 years old on the clinical structure of tuberculosis and epidemic risk of detected patients.Subjects and Methods: 1,679 children aged 7-15 ill with tuberculosis.Result. The
Externí odkaz:
https://doaj.org/article/05f5bba978984d309fb52134ee1f347e
Publikováno v:
Туберкулез и болезни лёгких, Vol 98, Iss 7, Pp 44-50 (2020)
To manage autonomic disorders in adolescents with tuberculosis, 100 people from 12 to 15 years old were examined and randomly divided into two groups: Group 1 received standard anti-tuberculosis therapy, and in Group 2, additionally to standard thera
Externí odkaz:
https://doaj.org/article/1d99d5bee37f49f0a3643b823b1e3b45
Publikováno v:
Туберкулез и болезни лёгких, Vol 98, Iss 7, Pp 56-62 (2020)
The objective of the study: to perform the multivariate analysis of treatment outcomes in patients with multiple/extensive drug resistant tuberculosis (MDR/XDR TB), including those with HIV infection, whose chemotherapy regimens included bedaquiline.
Externí odkaz:
https://doaj.org/article/6f4bc3f16a9141cd816698f93e3d9245
Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis
Publikováno v:
Фармакоэкономика, Vol 14, Iss 2 (2021)
Treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) is a current problem worldwide. Currently, special attention is paid to the possibility of using new high-cost chemotherapy regimens in the treatment of MDR
Externí odkaz:
https://doaj.org/article/0eb1eba2b6a74a90939949c0e61fd5fa